Perrigue P, Rakoczy M, Pawlicka K, Belter A, Giel Pietraszuk M, Naskret Barciszewska M, et al. Cancer Stem Cell-Inducing Media Activates Senescence Reprogramming in Fibroblasts. Cancers (Basel). 2020;12: pubmed publisher

Malinczak C, Rasky A, Fonseca W, Schaller M, Allen R, Ptaschinski C, et al. Upregulation of H3K27 Demethylase KDM6 During Respiratory Syncytial Virus Infection Enhances Proinflammatory Responses and Immunopathology. J Immunol. 2020;204:159-168 pubmed publisher

Benedetti R, Dell aversana C, De Marchi T, Rotili D, Liu N, Novakovic B, et al. Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast Cancer. Cancers (Basel). 2019;11: pubmed publisher

Yu J, Wang L, Pei P, Li X, Wu J, Qiu Z, et al. Reduced H3K27me3 leads to abnormal Hox gene expression in neural tube defects. Epigenetics Chromatin. 2019;12:76 pubmed publisher

Zou S, Zhang D, Xu Z, Wen X, Zhang Y. JMJD3 promotes the epithelial-mesenchymal transition and migration of glioma cells via the CXCL12/CXCR4 axis. Oncol Lett. 2019;18:5930-5940 pubmed publisher

Kumar B, Elsässer S. Quantitative Multiplexed ChIP Reveals Global Alterations that Shape Promoter Bivalency in Ground State Embryonic Stem Cells. Cell Rep. 2019;28:3274-3284.e5 pubmed publisher

Stowers R, Shcherbina A, Israeli J, Gruber J, Chang J, Nam S, et al. Matrix stiffness induces a tumorigenic phenotype in mammary epithelium through changes in chromatin accessibility. Nat Biomed Eng. 2019;3:1009-1019 pubmed publisher

Pediconi N, Salerno D, Lupacchini L, Angrisani A, Peruzzi G, De Smaele E, et al. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells. Cell Death Dis. 2019;10:518 pubmed publisher

Katagi H, Louis N, Unruh D, Sasaki T, He X, Zhang A, et al. Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma. Clin Cancer Res. 2019;: pubmed publisher

Lai J, Ge M, Shen S, Yang L, Jin T, Cao D, et al. Activation of NFKB-JMJD3 signaling promotes bladder fibrosis via boosting bladder smooth muscle cell proliferation and collagen accumulation. Biochim Biophys Acta Mol Basis Dis. 2019;: pubmed publisher

Kleszcz R, Szymanska A, Krajka Kuzniak V, Baer Dubowska W, Paluszczak J. Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells. Cell Oncol (Dordr). 2019;: pubmed publisher

Lin C, Hsu Y, Huang Y, Shih Y, Wang C, Chiang W, et al. A KDM6A-KLF10 reinforcing feedback mechanism aggravates diabetic podocyte dysfunction. EMBO Mol Med. 2019;11: pubmed publisher

Xiao Z, He Y, Liu C, Xiang L, Yi J, Wang M, et al. Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylation. Oncol Rep. 2019;41:2667-2678 pubmed publisher

Yamada T, Nabe S, Toriyama K, Suzuki J, Inoue K, Imai Y, et al. Histone H3K27 Demethylase Negatively Controls the Memory Formation of Antigen-Stimulated CD8+ T Cells. J Immunol. 2019;202:1088-1098 pubmed publisher

Zhang Y, Akumuo R, Espana R, Yan C, Gao W, Li Y. The histone demethylase KDM6B in the medial prefrontal cortex epigenetically regulates cocaine reward memory. Neuropharmacology. 2018;141:113-125 pubmed publisher

Lochmann T, Powell K, Ham J, Floros K, Heisey D, Kurupi R, et al. Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma. Sci Transl Med. 2018;10: pubmed publisher

Li Y, Zhang M, Sheng M, Zhang P, Chen Z, Xing W, et al. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia. J Cancer Res Clin Oncol. 2018;144:1065-1077 pubmed publisher

Fontcuberta PiSunyer M, Cervantes S, Miquel E, Mora Castilla S, Laurent L, Raya A, et al. Modulation of the endocrine transcriptional program by targeting histone modifiers of the H3K27me3 mark. Biochim Biophys Acta Gene Regul Mech. 2018;1861:473-480 pubmed publisher

Park J, Cho H, Oh H, Kim J, Seo S. AURKA Suppresses Leukemic THP-1 Cell Differentiation through Inhibition of the KDM6B Pathway. Mol Cells. 2018;41:444-453 pubmed publisher

Majumder S, Thieme K, Batchu S, Alghamdi T, Bowskill B, Kabir M, et al. Shifts in podocyte histone H3K27me3 regulate mouse and human glomerular disease. J Clin Invest. 2018;128:483-499 pubmed publisher

Nancy P, Siewiera J, Rizzuto G, Tagliani E, Osokine I, Manandhar P, et al. H3K27me3 dynamics dictate evolving uterine states in pregnancy and parturition. J Clin Invest. 2018;128:233-247 pubmed publisher

Mandal C, Kim S, Kang S, Chai J, Lee Y, Jung K, et al. GSK-J4-Mediated Transcriptomic Alterations in Differentiating Embryoid Bodies. Mol Cells. 2017;40:737-751 pubmed publisher

Taube J, Sphyris N, Johnson K, Reisenauer K, Nesbit T, Joseph R, et al. The H3K27me3-demethylase KDM6A is suppressed in breast cancer stem-like cells, and enables the resolution of bivalency during the mesenchymal-epithelial transition. Oncotarget. 2017;8:65548-65565 pubmed publisher

Morozov V, Li Y, Clowers M, Ishov A. Inhibitor of H3K27 demethylase JMJD3/UTX GSK-J4 is a potential therapeutic option for castration resistant prostate cancer. Oncotarget. 2017;8:62131-62142 pubmed publisher

Inoue S, Takahara S, Yoshikawa T, Niihori T, Yanai K, Matsubara Y, et al. Activated Braf induces esophageal dilation and gastric epithelial hyperplasia in mice. Hum Mol Genet. 2017;26:4715-4727 pubmed publisher

Liu P, Wang H, Li X, Chao T, Teav T, Christen S, et al. ?-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat Immunol. 2017;18:985-994 pubmed publisher

Clancy K, Russell A, Subramanian V, Nguyen H, Qian Y, Campbell R, et al. Citrullination/Methylation Crosstalk on Histone H3 Regulates ER-Target Gene Transcription. ACS Chem Biol. 2017;12:1691-1702 pubmed publisher

Guo Y, Walsh A, Fearon U, Smith M, Wechalekar M, Yin X, et al. CD40L-Dependent Pathway Is Active at Various Stages of Rheumatoid Arthritis Disease Progression. J Immunol. 2017;198:4490-4501 pubmed publisher

Wang F, Lian W, Lee M, Weng W, Huang Y, Chen Y, et al. Histone demethylase UTX counteracts glucocorticoid deregulation of osteogenesis by modulating histone-dependent and -independent pathways. J Mol Med (Berl). 2017;95:499-512 pubmed publisher

Cárdenas H, Zhao J, Vieth E, Nephew K, Matei D. EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells. Oncotarget. 2016;7:84453-84467 pubmed publisher

Doñas C, Carrasco M, Fritz M, Prado C, Tejon G, Osorio Barrios F, et al. The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs. J Autoimmun. 2016;75:105-117 pubmed publisher

Palomer E, Carretero J, Benvegnù S, Dotti C, Martin M. Neuronal activity controls Bdnf expression via Polycomb de-repression and CREB/CBP/JMJD3 activation in mature neurons. Nat Commun. 2016;7:11081 pubmed publisher

Nagarsheth N, Peng D, Kryczek I, Wu K, Li W, Zhao E, et al. PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer. Cancer Res. 2016;76:275-82 pubmed publisher

Tennant B, Hurley P, Dhillon J, Gill A, Whiting C, Hoffman B. The TrxG Complex Mediates Cytokine Induced De Novo Enhancer Formation in Islets. PLoS ONE. 2015;10:e0141470 pubmed publisher

Chakroun I, Yang D, Girgis J, Gunasekharan A, Phenix H, Kærn M, et al. Genome-wide association between Six4, MyoD, and the histone demethylase Utx during myogenesis. FASEB J. 2015;29:4738-55 pubmed publisher

Kamikawa Y, Donohoe M. Histone demethylation maintains Prdm14 and Tsix expression and represses xIst in embryonic stem cells. PLoS ONE. 2015;10:e0125626 pubmed publisher

Inoue S, Moriya M, Watanabe Y, Miyagawa Tomita S, Niihori T, Oba D, et al. New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome. Hum Mol Genet. 2014;23:6553-66 pubmed publisher